Current Neuro-Oncology
Volume
1 Supplement 3
31 December 1999
Home > Publications > Current Neuro-Oncology > Volume 1, Year 1999 > Supplement 3, 31 December
Literature selection: 1995 – 1998
▫Finlay
JL, Boyett JM, Yates AJ, Wisoff JH, Milstein JM, Geyer JR,
Bertolone SJ, McGuire P, Cherlow JM, Tefft M, et al.
Randomized
phase III trial in childhood high-grade astrocytoma comparing
vincristine, lomustine, and prednisone with the
eight-drugs-in-1-day regimen. Childrens Cancer Group.
J
Clin Oncol.
1995 Jan 1;13(1):112-23. doi:
10.1200/JCO.1995.13.1.112. PMID:
7799011. Interventional study. ˍ
▫Janss
AJ, Grundy R, Cnaan A, Savino PJ, Packer RJ, Zackai EH, Goldwein
JW, Sutton LN, Radcliffe J, Molloy PT, et al.
Optic
pathway and hypothalamic/chiasmatic gliomas in children younger
than age 5 years with a 6-year follow-up.
Cancer.
1995 Feb 15;75(4):1051-9. doi:
10.1002/1097-0142(19950215)75:4<1051::aid-cncr2820750423>3.0.co;2-s.
PMID:
7842408. Observational study. ˍ
▫Pollack
IF, Claassen D, al-Shboul Q, Janosky JE, Deutsch M.
Low-grade
gliomas of the cerebral hemispheres in children: an analysis of 71
cases.
J
Neurosurg.
1995 Apr;82(4):536-47. doi:
10.3171/jns.1995.82.4.0536. PMID:
7897512. Observational study. ˍ
▫Wellenreuther
R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V,
Gusella JF, Wiestler OD, von Deimling A.
Analysis
of the neurofibromatosis 2 gene reveals molecular variants of
meningioma.
Am
J Pathol.
1995 Apr;146(4):827-32. PMCID:
PMC1869258. PMID:
7717450. Laboratory investigation. ˍ
▫Brem
H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K,
Sisti M, Brem S, Mohr G, Muller P, Morawetz R, Schold SC.
Placebo-controlled
trial of safety and efficacy of intraoperative controlled delivery
by biodegradable polymers of chemotherapy for recurrent gliomas.
The Polymer-brain Tumor Treatment Group.
Lancet.
1995 Apr 22;345(8956):1008-12. doi:
10.1016/s0140-6736(95)90755-6. PMID:
7723496. Interventional study. ˍ
▫Zorludemir
S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer
FB.
Clear
cell meningioma. A clinicopathologic study of a potentially
aggressive variant of meningioma.
Am
J Surg Pathol.
1995 May 1;19(5):493-505. doi:
10.1097/00000478-199505000-00001. PMID:
7726360. Laboratory investigation. ˍ
>>>
Shen
F, Decosterd LA, Gander M, Leyvraz S, Biollax J, Lejeune
F.
Determination
of temozolomide in human plasma and urine by high-performance
liquid chromatography after solid-phase extraction.
J
Chromatogr B Biomed Appl. 1995 May 19;667(2):291-300∟.
doi: 10.1016/0378-4347(95)00040-p∟.
PMID: 7663702∟.
Laboratory investigation.
Friedman
HS, Dolan ME, Pegg AE, Marcelli S, Keir S, Catino JJ, Bigner DD,
Schold SC Jr.
Activity
of temozolomide in the treatment of central nervous system tumor
xenografts.
Cancer
Res. 1995 Jul 1;55(13):2853-7∟.
PMID: 7796412∟.
Laboratory investigation.
▫Bailey
CC, Gnekow A, Wellek S, Jones M, Round C, Brown J, Phillips A,
Neidhardt MK.
Prospective
randomised trial of chemotherapy given before radiotherapy in
childhood medulloblastoma. International Society of Paediatric
Oncology (SIOP) and the (German) Society of Paediatric Oncology
(GPO): SIOP II.
Med
Pediatr Oncol. 1995 Sep;25(3):166-78∟.
doi: 10.1002/mpo.2950250303∟.
PMID: 7623725∟.
Interventional study.
▫Sutton
LN, Molloy PT, Sernyak H, Goldwein J, Phillips PL, Rorke LB,
Moshang T Jr, Lange B, Packer RJ.
Long-term
outcome of hypothalamic/chiasmatic astrocytomas in children
treated with conservative surgery.
J
Neurosurg. 1995 Oct;83(4):583-9∟.
doi: 10.3171/jns.1995.83.4.0583∟.
PMID: 7674005∟.
Observational study.
▫Simon
M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A,
Warnick RE, Tew JM Jr, Menon AG.
Allelic
losses on chromosomes 14, 10, and 1 in atypical and malignant
meningiomas: a genetic model of meningioma progression.
Cancer
Res. 1995 Oct 15;55(20):4696-701∟.
PMID: 7553651∟.
Laboratory investigation.
▫Elexpuru-Camiruaga
J, Buxton N, Kandula V, Dias PS, Campbell D, McIntosh J, Broome J,
Jones P, Inskip A, Alldersea J, et al.
Susceptibility
to astrocytoma and meningioma: influence of allelism at
glutathione S-transferase (GSTT1 and GSTM1) and cytochrome P-450
(CYP2D6) loci.
Cancer
Res. 1995 Oct 1;55(19):4237-9∟.
PMID: 7671227∟.
Laboratory investigation.
▫Couldwell
WT, Fukushima T, Giannotta SL, Weiss MH.
Petroclival
meningiomas: surgical experience in 109 cases.
J
Neurosurg. 1996 Jan;84(1):20-8∟.
doi: 10.3171/jns.1996.84.1.0020∟.
PMID: 8613831∟.
Observational study.
▫Albright
AL, Wisoff JH, Zeltzer PM, Boyett JM, Rorke LB, Stanley P.
Effects
of medulloblastoma resections on outcome in children: a report
from the Children's Cancer Group.
Neurosurgery.
1996 Feb 1;38(2):265-71∟.
doi: 10.1097/00006123-199602000-00007∟.
PMID: 8869053∟.
Observational study.
▫Milosevic
MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ.
Radiotherapy
for atypical or malignant intracranial meningioma.
Int
J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):817-22∟.
doi: 10.1016/0360-3016(95)02166-3∟.
PMID: 8598358∟.
Observational study.
Bobola
MS, Tseng SH, Blank A, Berger MS, Silber JR.
Role
of O6-methylguanine-DNA methyltransferase in resistance of human
brain tumor cell lines to the clinically relevant methylating
agents temozolomide and streptozotocin.
Clin
Cancer Res. 1996 Apr;2(4):735-41∟.
PMID: 9816224∟.
Laboratory investigation.
Devineni
D, Klein-Szanto A, Gallo JM.
Uptake
of temozolomide in a rat glioma model in the presence and absence
of the angiogenesis inhibitor TNP-470.
Cancer
Res. 1996 May 1;56(9):1983-7∟.
PMID: 8616836∟.
Laboratory investigation.
Wedge
SR, Newlands ES.
O6-benzylguanine
enhances the sensitivity of a glioma xenograft with low
O6-alkylguanine-DNA alkyltransferase activity to temozolomide and
BCNU.
Br
J Cancer. 1996 May 1;73(9):1049-52∟.
doi: 10.1038/bjc.1996.203∟.
PMID: 8624262∟.
Laboratory investigation.
Horwitz NH.
Harvey
Cushing (1869-1939).
Neurosurgery.
1996 Jul;39(1):205-9∟.
doi: 10.1097/00006123-199607000-00050∟.
PMID: 8805162∟.
Historical perspective.
▫Mathiesen
T, Lindquist C, Kihlström L, Karlsson B.
Recurrence
of cranial base meningiomas.
Neurosurgery.
1996 Jul 1;39(1):2-7∟.
doi: 10.1097/00006123-199607000-00002∟.
PMID: 8805134∟.
Observational study.
▫Carneiro
SS, Scheithauer BW, Nascimento AG, Hirose T, Davis DH.
Solitary
fibrous tumor of the meninges: a lesion distinct from fibrous
meningioma. A clinicopathologic and immunohistochemical study.
Am
J Clin Pathol. 1996 Aug 1;106(2):217-24∟.
doi: 10.1093/ajcp/106.2.217∟.
PMID: 8712177∟.
Case report.
▫Scerrati
M, Roselli R, Iacoangeli M, Pompucci A, Rossi GF.
Prognostic
factors in low grade (WHO grade II) gliomas of the cerebral
hemispheres: the role of surgery.
J
Neurol Neurosurg Psychiatry. 1996 Sep 1;61(3):291-6∟.
doi: 10.1136/jnnp.61.3.291∟.
PMID: 8795601∟.
Observational study.
▫Karim
AB, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG,
Mascarenhas F, Horiot JC, Parvinen LM, van Reijn M, Jager JJ,
Fabrini MG, van Alphen AM, Hamers HP, Gaspar L, Noordman E,
Pierart M, van Glabbeke M.
A
randomized trial on dose-response in radiation therapy of
low-grade cerebral glioma: European Organization for Research and
Treatment of Cancer (EORTC) Study 22844.
Int
J Radiat Oncol Biol Phys. 1996 Oct 1;36(3):549-56∟.
doi: 10.1016/s0360-3016(96)00352-5∟.
PMID: 8948338∟.
Interventional study.
▫De
Jesús O, Sekhar LN, Parikh HK, Wright DC, Wagner
DP.
Long-term
follow-up of patients with meningiomas involving the cavernous
sinus: recurrence, progression, and quality of life.
Neurosurgery.
1996 Nov 1;39(5):915-9∟.
doi: 10.1097/00006123-199611000-00005∟.
PMID: 8905745∟.
Observational study.
Newlands
ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton
MH, Colquhoun I, Lewis P, Rice-Edwards JM, Illingworth RD,
Richards PG.
The
Charing Cross Hospital experience with temozolomide in patients
with gliomas.
Eur
J Cancer. 1996 Dec 1;32A(13):2236-41∟.
doi: 10.1016/s0959-8049(96)00258-4∟.
PMID: 9038604∟.
Observational study.
▫Hsu
DW, Efird JT, Hedley-Whyte ET.
Progesterone
and estrogen receptors in meningiomas: prognostic
considerations.
J
Neurosurg. 1997 Jan;86(1):113-20∟.
doi: 10.3171/jns.1997.86.1.0113∟.
PMID: 8988089∟.
Observational study.
Wedge
SR, Porteous JK, Glaser MG, Marcus K, Newlands ES.
In
vitro evaluation of temozolomide combined with
X-irradiation.
Anticancer
Drugs. 1997 Jan;8(1):92-7∟.
doi: 10.1097/00001813-199701000-00013∟.
PMID: 9147618∟.
Laboratory investigation.
▫Gaspar
L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna
WG, Byhardt R.
Recursive
partitioning analysis (RPA) of prognostic factors in three
Radiation Therapy Oncology Group (RTOG) brain metastases
trials.
Int
J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51∟.
doi: 10.1016/s0360-3016(96)00619-0∟.
PMID: 9128946∟.
Observational study.
▫Saas
P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G,
French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY.
Fas
ligand expression by astrocytoma in vivo: maintaining immune
privilege in the brain?
J
Clin Invest. 1997 Mar 15;99(6):1173-8∟.
doi: 10.1172/JCI119273∟.
PMID: 9077524∟.
Laboratory investigation.
▫Li
J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J,
Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC,
Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R.
PTEN,
a putative protein tyrosine phosphatase gene mutated in human
brain, breast, and prostate cancer.
Science.
1997 Mar 28;275(5308):1943-7∟.
doi: 10.1126/science.275.5308.1943∟.
PMID: 9072974∟.
Laboratory investigation.
▫Langford
LA, Piatyszek MA, Xu R, Schold SC Jr, Wright WE, Shay
JW.
Telomerase
activity in ordinary meningiomas predicts poor outcome.
Hum
Pathol. 1997 Apr;28(4):416-20∟.
doi: 10.1016/s0046-8177(97)90029-0∟.
PMID: 9104940∟.
Laboratory investigation.
▫Leighton
C, Fisher B, Bauman G, Depiero S, Stitt L, MacDonald D, Cairncross
G.
Supratentorial
low-grade glioma in adults: an analysis of prognostic factors and
timing of radiation.
J
Clin Oncol. 1997 Apr 1;15(4):1294-301∟.
doi: 10.1200/JCO.1997.15.4.1294∟.
PMID: 9193320∟.
Observational study.
▫Steck
PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford
LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B,
Teng DH, Tavtigian SV.
Identification
of a candidate tumour suppressor gene, MMAC1, at chromosome
10q23.3 that is mutated in multiple advanced cancers.
Nat
Genet. 1997 Apr 1;15(4):356-62∟.
doi: 10.1038/ng0497-356∟.
PMID: 9090379∟.
Laboratory investigation.
▫Packer
RJ, Ater J, Allen J, Phillips P, Geyer R, Nicholson HS, Jakacki R,
Kurczynski E, Needle M, Finlay J, Reaman G, Boyett JM.
Carboplatin
and vincristine chemotherapy for children with newly diagnosed
progressive low-grade gliomas.
J
Neurosurg. 1997 May;86(5):747-54∟.
doi: 10.3171/jns.1997.86.5.0747∟.
PMID: 9126887∟.
Observational study.
▫Palma
L, Celli P, Franco C, Cervoni L, Cantore G.
Long-term
prognosis for atypical and malignant meningiomas: a study of 71
surgical cases.
J
Neurosurg. 1997 May;86(5):793-800∟.
doi: 10.3171/jns.1997.86.5.0793∟.
PMID: 9126894∟.
Observational study.
▫Prados
MD, Edwards MS, Rabbitt J, Lamborn K, Davis RL, Levin VA.
Treatment
of pediatric low-grade gliomas with a nitrosourea-based multiagent
chemotherapy regimen.
J
Neurooncol. 1997 May;32(3):235-41∟.
doi: 10.1023/a:1005736104205∟.
PMID: 9049885∟.
Interventional study.
▫Schrell
UM, Rittig MG, Anders M, Koch UH, Marschalek R, Kiesewetter F,
Fahlbusch R.
Hydroxyurea
for treatment of unresectable and recurrent meningiomas. II.
Decrease in the size of meningiomas in patients treated with
hydroxyurea.
J
Neurosurg. 1997 May;86(5):840-4∟.
doi: 10.3171/jns.1997.86.5.0840∟.
PMID: 9126900∟.
Interventional study.
▫Provias
J, Claffey K, delAguila L, Lau N, Feldkamp M, Guha A.
Meningiomas:
role of vascular endothelial growth factor/vascular permeability
factor in angiogenesis and peritumoral edema.
Neurosurgery.
1997 May 1;40(5):1016-26∟.
doi: 10.1097/0006123-199705000-00027∟.
PMID: 9149260∟.
Laboratory investigation.
Dhodapkar
M, Rubin J, Reid JM, Burch PA, Pitot HC, Buckner JC, Ames MM,
Suman VJ.
Phase
I trial of temozolomide (NSC 362856) in patients with advanced
cancer.
Clin
Cancer Res. 1997 Jul;3(7):1093-100∟.
PMID: 9815788∟.
Interventional study.
Friedman
HS, Johnson SP, Dong Q, Schold SC, Rasheed BK, Bigner SH,
Ali-Osman F, Dolan E, Colvin OM, Houghton P, Germain G, Drummond
JT, Keir S, Marcelli S, Bigner DD, Modrich P.
Methylator
resistance mediated by mismatch repair deficiency in a
glioblastoma multiforme xenograft.
Cancer
Res. 1997 Jul 1;57(14):2933-6∟.
PMID: 9230204∟.
Laboratory investigation.
▫Gilbertson
RJ, Perry RH, Kelly PJ, Pearson AD, Lunec J.
Prognostic
significance of HER2 and HER4 coexpression in childhood
medulloblastoma.
Cancer
Res. 1997 Aug 1;57(15):3272-80∟.
PMID: 9242460∟.
Laboratory investigation.
▫Goodrich
LV, Milenković L, Higgins KM, Scott MP.
Altered
neural cell fates and medulloblastoma in mouse patched
mutants.
Science.
1997 Aug 22;277(5329):1109-13∟.
doi: 10.1126/science.277.5329.1109∟.
PMID: 9262482∟.
Laboratory investigation.
Bower
M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H,
Colquhoun I, Lewis P, Brampton MH.
Multicentre
CRC phase II trial of temozolomide in recurrent or progressive
high-grade glioma.
Cancer
Chemother Pharmacol. 1997 Sep;40(6):484-8∟.
doi: 10.1007/s002800050691∟.
PMID: 9332462∟.
Interventional study
▫Condra
KS, Buatti JM, Mendenhall WM, Friedman WA, Marcus RB Jr, Rhoton
AL.
Benign
meningiomas: primary treatment selection affects survival.
Int
J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):427-36∟.
doi: 10.1016/s0360-3016(97)00317-9∟.
PMID: 9308947∟.
Observational study.
▫Lote
K, Egeland T, Hager B, Stenwig B, Skullerud K, Berg-Johnsen J,
Storm-Mathisen I, Hirschberg H.
Survival,
prognostic factors, and therapeutic efficacy in low-grade glioma:
a retrospective study in 379 patients.
J
Clin Oncol. 1997 Sep 1;15(9):3129-40∟.
doi: 10.1200/JCO.1997.15.9.3129∟.
PMID: 9294476∟.
Observational study.
▫Perry
A, Scheithauer BW, Nascimento AG.
The
immunophenotypic spectrum of meningeal hemangiopericytoma: a
comparison with fibrous meningioma and solitary fibrous tumor of
meninges.
Am
J Surg Pathol. 1997 Nov;21(11):1354-60∟.
doi: 10.1097/00000478-199711000-00010∟.
PMID: 9351573∟.
Laboratory investigation˰
▫Perry
A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.
Meningioma
grading: an analysis of histologic parameters.
Am
J Surg Pathol. 1997 Dec;21(12):1455-65∟.
doi: 10.1097/00000478-199712000-00008∟.
PMID: 9414189∟.
Observational study˰
▫Weber
RG, Boström J, Wolter M, Baudis M, Collins VP, Reifenberger
G, Lichter P.
Analysis
of genomic alterations in benign, atypical, and anaplastic
meningiomas: toward a genetic model of meningioma
progression.
Proc
Natl Acad Sci USA. 1997 Dec 23;94(26):14719-24∟.
doi: 10.1073/pnas.94.26.14719∟.
PMID: 9405679∟.
Laboratory investigation.
▫Boström
J, Cobbers JM, Wolter M, Tabatabai G, Weber RG, Lichter P, Collins
VP, Reifenberger G.
Mutation
of the PTEN (MMAC1) tumor suppressor gene in a subset of
glioblastomas but not in meningiomas with loss of chromosome arm
10q.
Cancer
Res. 1998 Jan 1;58(1):29-33∟.
PMID: 9426052∟.
Laboratory investigation.
Moore
MJ, Feld R, Hedley D, Oza A, Siu LL.
A
phase II study of temozolomide in advanced untreated pancreatic
cancer.
Invest
New Drugs. 1998 Mar;16(1):77-9∟.
doi: 10.1023/a:1006043332368∟.
PMID: 9740547∟.
Interventional study.
▫Hakim
R, Alexander E 3rd, Loeffler JS, Shrieve DC, Wen P, Fallon MP,
Stieg PE, Black PM.
Results
of linear accelerator-based radiosurgery for intracranial
meningiomas.
Neurosurgery.
1998 Mar 1;42(3):446-53∟.
doi: 10.1097/00006123-199803000-00002∟.
PMID: 9526976∟.
Observational study.
▫Subach
BR, Lunsford LD, Kondziolka D, Maitz AH, Flickinger JC.
Management
of petroclival meningiomas by stereotactic
radiosurgery.
Neurosurgery.
1998 Mar 1;42(3):437-43∟.
doi: 10.1097/00006123-199803000-00001∟.
PMID: 9526975∟.
Observational study.
▫Dziuk
TW, Woo S, Butler EB, Thornby J, Grossman R, Dennis WS, Lu H,
Carpenter LS, Chiu JK.
Malignant
meningioma: an indication for initial aggressive surgery and
adjuvant radiotherapy.
J
Neurooncol. 1998 Apr;37(2):177-88∟.
doi: 10.1023/a:1005853720926∟.
PMID: 9524097∟.
Observational study.
▫Mulhern
RK, Kepner JL, Thomas PR, Armstrong FD, Friedman HS, Kun
LE.
Neuropsychologic
functioning of survivors of childhood medulloblastoma randomized
to receive conventional or reduced-dose craniospinal irradiation:
a Pediatric Oncology Group study.
J
Clin Oncol. 1998 May 1;16(5):1723-8∟.
doi: 10.1200/JCO.1998.16.5.1723∟.
PMID: 9586884∟.
Interventional study.
▫van
Veelen ML, Avezaat CJ, Kros JM, van Putten W, Vecht C.
Supratentorial
low grade astrocytoma: prognostic factors, dedifferentiation, and
the issue of early versus late surgery.
J
Neurol Neurosurg Psychiatry. 1998 May 1;64(5):581-7∟.
doi: 10.1136/jnnp.64.5.581∟.
PMID: 9598670∟.
Observational study.
▫Perry
A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM.
The
prognostic significance of MIB-1, p53, and DNA flow cytometry in
completely resected primary meningiomas.
Cancer.
1998 Jun 1;82(11):2262-9∟.
doi:
10.1002/(SICI)1097-0142(19980601)82:11<2262::AID-CNCR23>3.0.CO;2-R∟.
PMID: 9610708∟.
Observational study.
Meikle
SR, Matthews JC, Brock CS, Wells P, Harte RJ, Cunningham VJ, Jones
T, Price P.
Pharmacokinetic
assessment of novel anti-cancer drugs using spectral analysis and
positron emission tomography: a feasibility study.
Cancer
Chemother Pharmacol. 1998 Jul 1;42(3):183-93∟.
doi: 10.1007/s002800050804∟.
PMID: 9685053∟.
Observational study.
Ma
J, Fei ZL, Klein-Szanto A, Gallo JM.
Modulation
of angiogenesis by human glioma xenograft models that
differentially express vascular endothelial growth factor.
Clin
Exp Metastasis. 1998 Aug;16(6):559-68∟.
doi: 10.1023/a:1006598419541∟.
PMID: 9872603∟.
Laboratory investigation.
▫Burger
PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner
PK, Kun LE, Perlman EJ.
Atypical
teratoid/rhabdoid tumor of the central nervous system: a highly
malignant tumor of infancy and childhood frequently mistaken for
medulloblastoma: a Pediatric Oncology Group study.
Am
J Surg Pathol. 1998 Sep;22(9):1083-92∟.
doi: 10.1097/00000478-199809000-00007∟.
PMID: 9737241∟.
Observational study˰
Estlin
EJ, Lashford L, Ablett S, Price L, Gowing R, Gholkar A, Kohler J,
Lewis IJ, Morland B, Pinkerton CR, Stevens MC, Mott M, Stevens R,
Newell DR, Walker D, Dicks-Mireaux C, McDowell H, Reidenberg P,
Statkevich P, Marco A, Batra V, Dugan M, Pearson AD.
Phase
I study of temozolomide in paediatric patients with advanced
cancer. United Kingdom Children's Cancer Study Group.
Br
J Cancer. 1998 Sep 1;78(5):652-61∟.
doi: 10.1038/bjc.1998.555∟.
PMID: 9744506∟.
Interventional study.
▫Kondziolka
D, Flickinger JC, Perez B.
Judicious
resection and/or radiosurgery for parasagittal meningiomas:
outcomes from a multicenter review. Gamma Knife Meningioma Study
Group.
Neurosurgery.
1998 Sep 1;43(3):405-13∟.
doi: 10.1097/00006123-199809000-00001∟.
PMID: 9733295∟.
Observational study.
Marzolini
C, Decosterd LA, Shen F, Gander M, Leyvraz S, Bauer J, Buclin T,
Biollaz J, Lejeune F.
Pharmacokinetics
of temozolomide in association with fotemustine in malignant
melanoma and malignant glioma patients: comparison of oral,
intravenous, and hepatic intra-arterial administration.
Cancer
Chemother Pharmacol. 1998 Oct;42(6):433-40∟.
doi: 10.1007/s002800050842∟.
PMID: 9788568∟.
Observational study.
Brock
CS, Newlands ES, Wedge SR, Bower M, Evans H, Colquhoun I, Roddie
M, Glaser M, Brampton MH, Rustin GJ.
Phase
I trial of temozolomide using an extended continuous oral
schedule.
Cancer
Res. 1998 Oct 1;58(19):4363-7∟.
PMID: 9766665∟.
Interventional study.
▫Stafford
SL, Perry A, Suman VJ, Meyer FB, Scheithauer BW, Lohse CM, Shaw
EG.
Primarily
resected meningiomas: outcome and prognostic factors in 581 Mayo
Clinic patients, 1978 through 1988.
Mayo
Clin Proc. 1998 Oct 1;73(10):936-42∟.
doi: 10.4065/73.10.936∟.
PMID: 9787740∟.
Observational study.
▫Cairncross
JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR,
Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA, Louis DN.
Specific
genetic predictors of chemotherapeutic response and survival in
patients with anaplastic oligodendrogliomas.
J
Natl Cancer Inst. 1998 Oct 7;90(19):1473-9∟.
doi: 10.1093/jnci/90.19.1473∟.
PMID: 9776413∟.
Observational study.
▫Patchell
RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ,
Markesbery WR, Foon KA, Young B.
Postoperative
radiotherapy in the treatment of single metastases to the brain: a
randomized trial.
JAMA.
1998 Nov 4;280(17):1485-9∟.
doi: 10.1001/jama.280.17.1485∟.
PMID: 9809728∟.
Interventional study.
*Friedman
HS, McLendon RE, Kerby T, Dugan M, Bigner SH, Henry AJ, Ashley DM,
Krischer J, Lovell S, Rasheed K, Marchev F, Seman AJ, Cokgor I,
Rich J, Stewart E, Colvin OM, Provenzale JM, Bigner DD, Haglund
MM, Friedman AH, Modrich PL.
DNA
mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis
and response to Temodal in newly diagnosed malignant glioma.
J
Clin Oncol. 1998 Dec 1;16(12):3851-7∟.
doi: 10.1200/JCO.1998.16.12.3851∟.
PMID: 9850030∟.
Interventional study.